Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma
Josep M. Llovet, Valerie Paradis, Masatoshi Kudo, Jessica Zucman‐Rossi – 18 May 2011
Josep M. Llovet, Valerie Paradis, Masatoshi Kudo, Jessica Zucman‐Rossi – 18 May 2011
Jason M. Vanatta, Kian A. Modanlou, Amanda G. Dean, Nosratollah Nezakatgoo, Luis Campos, Satheesh Nair, James D. Eason – 18 May 2011 – Hepatic sarcoidosis is a rare indication for liver transplantation. Using the United Network for Organ Sharing (UNOS)/Organ Procurement and Transplantation Network (OPTN) database, we evaluated patient and graft survival after orthotopic liver transplantation for sarcoidosis between October 1987 and December 2007.
Bong‐Wan Kim, Weiguang Xu, Hee‐Jung Wang, Yong‐Keun Park, Kwangil Lee, Myung‐Wook Kim – 18 May 2011 – To determine the feasibility of volumetric criteria without anatomic exclusion for the selection of right posterior sector (RPS) grafts for adult‐to‐adult living donor liver transplantation (LDLT), we reviewed and compared our transplant data for RPS grafts and right lobe (RL) grafts.
Francis Y. Yao, Stefan Breitenstein, Christoph E. Broelsch, Jean‐Francois Dufour, Morris Sherman – 16 May 2011
Norman Kneteman, Tito Livraghi, David Madoff, Eduardo de Santibañez, Michael Kew – 16 May 2011
Giacomo Germani, Kurinchi Gurusamy, Matteo Garcovich, Christian Toso, Giuseppe Fede, Alan Hemming, Kyung‐Suk Suh, Achim Weber, Andrew Kenneth Burroughs – 16 May 2011
Kwang‐Woong Lee, Seong Hoon Kim, Sung‐Sik Han, Young‐Kyu Kim, Seong Yeon Cho, Tae You, Sang‐Jae Park – 16 May 2011 – Over a period of 2 years, we used an upper midline incision (UMI) without laparoscopic assistance in 143 consecutive living donor partial hepatectomy (LDPH) procedures, regardless of the graft type or the donor age, sex, body mass index, or body shape. Here we report surgical recommendations based on our experience with the use of UMIs in this context.
Michael K. Connolly, Diego Ayo, Ashim Malhotra, Michael Hackman, Andrea S. Bedrosian, Junaid Ibrahim, Napoleon E. Cieza‐Rubio, Andrew H. Nguyen, Justin R. Henning, Monica Dorvil‐Castro, H. Leon Pachter, George Miller – 13 May 2011 – Acetaminophen (APAP) overdose is one of the most frequent causes of acute liver failure in the United States and is primarily mediated by toxic metabolites that accumulate in the liver upon depletion of glutathione stores.
Chih‐Wen Lin, Wendy M. Mars, Shirish Paranjpe, Shashikiran Donthamsetty, Vishakha S. Bhave, Liang‐I Kang, Anne Orr, William C. Bowen, Aaron W. Bell, George K. Michalopoulos – 13 May 2011 – Glypican 3 (GPC3) is a family of glycosylphosphatidylinositol‐anchored, cell‐surface heparan sulfate proteoglycans. Loss‐of‐function mutations of GPC3 cause Simpson‐Golabi‐Behmel syndrome characterized by overgrowth of multiple organs, including liver.
Haruhiko Yoshida, Yasushi Shiratori, Masatoshi Kudo, Shuichiro Shiina, Toshihiko Mizuta, Masamichi Kojiro, Kyosuke Yamamoto, Yukihiro Koike, Kenichi Saito, Nozomu Koyanagi, Takao Kawabe, Seiji Kawazoe, Haruhiko Kobashi, Hiroshi Kasugai, Yukio Osaki, Yasuyuki Araki, Namiki Izumi, Hiroko Oka, Kunihiko Tsuji, Joji Toyota, Toshihito Seki, Toshiya Osawa, Naohiko Masaki, Masao Ichinose, Masataka Seike, Akihisa Ishikawa, Yoshiyuki Ueno, Kazumi Tagawa, Ryoko Kuromatsu, Shotaro Sakisaka, Hiroshi Ikeda, Hidekatsu Kuroda, Hiroyuki Kokuryu, Tatsuya Yamashita, Isao Sakaida, Tetsuo Katamoto, Kentaro Kiku